Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

A woman with complete hair loss and severe hyperthyroidism was successfully treated with azathioprine and hydroxychloroquine.

The study concluded that patients with total hair loss and recurring hair loss had an earlier onset, longer-lasting condition, and a greater negative impact on their quality of life, with allergic conditions linked to more severe hair loss.

About half of people with mild alopecia areata see hair regrowth in a year, but relapses are common.

Scalp tinea versicolor can mimic alopecia areata but is treatable with antifungal medication.

Alopecia areata is an unpredictable autoimmune hair loss condition, treated based on severity, with half of patients regrowing hair within a year without treatment.

Alopecia areata causes significant emotional and social challenges, especially with more hair loss.

A man had both alopecia areata and lichen planus, which is uncommon.

Alopecia areata management involves explaining the condition, using treatments like steroids and immunotherapy, and providing support like counseling and wigs.

Permanent hair loss after a stem cell transplant can be a sign of chronic immune system attack on the scalp.

The document suggests a personalized treatment plan for alopecia areata based on the patient's age and hair loss severity, using a range of therapies ranked by effectiveness and safety.

The document concludes that a unique target-like hair regrowth pattern in alopecia areata may be more common than thought and should be properly identified.

Targeting specific T cells may help treat alopecia areata.

Half of people with Alopecia Areata may see hair regrowth within a year without treatment, but recovery is unpredictable.

Early treatment of COVID-19-related hair loss is crucial for better outcomes.

Alopecia areata is an autoimmune disease where T cells attack hair follicles.

Early intervention and patient education are crucial for managing alopecia areata.

Frontal fibrosing alopecia is increasingly affecting men, causing hair loss around the hairline and possibly other areas.

Alopecia areata is an autoimmune disease that targets hair follicles.

Alopecia universalis can be an early sign of HIV.

A woman's hair loss worsened after starting hepatitis C treatment due to immune changes in her hair follicles.

Alopecia areata is linked to reduced T cell function and auto-immunity.

Relapsing polychondritis might be linked to alopecia areata due to immune system factors.

The paper concludes that recognizing bitemporal alopecia areata is important for early treatment and preventing its progression.

Hair transplant surgery may cause alopecia areata, a new possible complication.

Alopecia areata may appear differently depending on the individual's type of hair loss and scalp condition.

The treatment with an oral drug and topical lotion is effective and well-tolerated for hair loss after COVID-19.